DOCSLIB.ORG

North Bristol NHS Trust (NBT) Is the Largest Trust in the South West Region, and One of the Largest Trusts in the Country

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
North Bristol NHS Trust (NBT) Is the Largest Trust in the South West Region, and One of the Largest Trusts in the Country SECTION 1 – SUMMARY OF POST Job Title: Consultant Immunologist, specialising in Immunodeficiency & Allergy (Replacement post) Grade: Consultant Directorate: Medicine Location/Base: Brunel Building, Southmead Hospital SECTION 2 – ABOUT THE TRUST North Bristol NHS Trust (NBT) is the largest Trust in the South West region, and one of the largest trusts in the country. It is a progressive and ambitious provider of health services, delivering for a large local population and with specialist regional services for major trauma, neurosciences, vascular centre, urology, plastics and burns, orthopaedics and renal services. With a turnover of £550m and 9,000 staff, our clinical teams have built a strong reputation for exceptional healthcare. NBT provides medical, surgical and maternity care for a population of approximately half a million people in the North Bristol, South Gloucestershire and North Somerset areas. In May 2014 the Trust relocated the majority of its acute services to the Brunel Building, one of the most advanced hospitals in Europe offering state-of-the-art care in a beautiful and purpose built environment, designed with the patients privacy and dignity in mind. As well as Southmead Hospital, the Trust also has Cosham Hospital, in Kingswood, that recently underwent a £19m refurbishment, the Bristol Centre for Enablement, at Cribbs Causeway (Bristol) and the Trust also runs children’s community health services across Bristol and South Gloucestershire. The Trust has University Teaching status and is associated with both the University of Bristol and the University of the West of England. Southmead Hospital is located to the North of Bristol and has easy access from the motorways (M32/M4/M5) and by public transport. For those who cycle, Bristol boasts excellent cycling facilities and was chosen as England’s first cycling city in 2008, and was the European green capital 2015. In 2014 Bristol was nominated by the Times as the best city to live in the UK, citing: “one of the lowest unemployment rates in the country, varied and beautiful housing stock, decent schools, buzzy culture and night life and access to some fantastic countryside”. The location also allows easy access to the town centre which has theatres, a large shopping centre and a historical harbour-side. There is an array of annual festivals and events including the Bristol International Balloon Fiesta and the Bristol Harbour Festival. SECTION 3 – THE WORK OF THE DEPARTMENT Type of test/Properties measured/Range of measurement The Department is the regional Immunology and Allergy service for the northern end of the southwest region. It has referrals from Avon, Gloucestershire, Wiltshire and Somerset, as well as outreach clinics. The Allergy service is fully accredited and provides for all allergy patients. This includes diagnosis and testing for allergy, desensitisation, challenge clinics, anaesthetic allergy clinics and a specialist urticaria service for omalizumab patients. This is supported by a nurse practitioner and a team of nurses. The Clinical Immunology service has a caseload of 160 antibody deficiency patients on immunoglobulin replacement therapy supervised by the consultants, with registrar and nursing support. It also has a number of other diagnosed and undiagnosed immunodeficiency patients which are being investigated or followed up. There is a paediatric immunology and allergy service which links to the Adult service with joint clinics (allergy) and transition clinics (immunodeficiency). There are joint meetings to discuss cases. Accreditation will be applied for in June 2020. In addition there are 3 satellite services for Immunology and allergy based in Bath, Taunton and Gloucester. They provide an outreach service. The commissioners have indicated that the service will be reformed with the service coming under Bristol for all patients, but with a local delivery. This is currently being modelled for feasibility. The department is a lively and active department with all consultants being involved in teaching, training and/or research. It has a good academic output as well as successful training. We are looking for an enthusiastic colleague(s) to join this team. Workload Type of activity Requests in year 2018/2019 Clinical Workload (Immunology and Allergy) 4000 (New cases 1300) Immunology % (approx.) 25% GPvs Secondary and tertiary care 75% GP referrals The repertoire of tests and breakdown of workload should be provided in sufficient detail to allow an appreciation of the breadth of activities undertaken in the laboratory. This should include information on tests referred externally. Note the method used for each test offered and the equipment available next to the workload list. Scope of Work: Immunopathology. The Following tests are carried out within the Department Immunology examination activities for the purpose of clinical diagnosis and Immunopathology oversite. Test Total NBT Total UBHT Total Weston Total tested VES V1 (COMMON WASP PHOSPHOLIPASE A1) 1 1 1 3 VES V5 (COMMON WASP ANTIGEN 5) 1 2 1 4 WINE (WHITE) 0 1 0 1 YEAST 2 2 1 5 ADALIMUMAB AB 110 0 17 127 ADALIMUMAB LEVEL 109 0 16 125 ALLERGEN NOT LISTED 112 8 2 122 API M1 (HONEY BEE PHOSPHOLIPASE A2) 1 4 1 6 APRICOT 3 3 0 6 AQUAPORIN 4 92 37 1 130 ARA H8 (PEANUT PR-10) 0 1 0 1 BETA-2-GLYCOPROTEIN 1 34 0 4 38 ANTI BASAL GANGLIA 1 0 0 1 CARDIAC 8 0 0 8 CALCIUM GATED CHANNEL 39 12 2 53 CSF NEURODEGENERATIVE MARKERS 46 0 0 46 ENTEROCYTE 16 0 0 16 GANGLIOSIDE SCREEN 125 15 0 140 HMGCOAR ANTIBODIES 7 0 0 7 HISTONE 9 0 0 9 INTRINSIC FACTOR ABS 527 283 189 999 INFLIXIMAB AB 25 0 20 45 INFLIXIMAB LEVELS 21 0 17 38 INSULIN ANTIBODIES 12 0 0 12 IMMUNOLOGY SENDAWAY NOT LISTED 216 2 0 218 POTASSIUM GATED CHANNEL 321 79 11 411 MYELIN ASSOCIATED GLYCOPROTEIN 28 17 2 47 MANNAN BINDING LECTIN 105 0 0 105 MANNOSE BINDING LECTIN PATHWAY 0 83 0 83 MUSCLE SPECIFIC KINASE ABS 56 53 0 109 FIXED NMDA RECEPTOR ANTIBODY 241 67 3 311 NEURONE SPECIFIC ENOLASE 0 10 0 10 ANTI OVARY ANTIBODIES 12 6 1 19 PNEUMOCOCCAL SEROLOGY 246 0 0 246 PNEUMOCOCCAL AB REFERRAL 247 0 0 247 INFLIXIMAB - REMSIMA 81 0 0 81 SKELETAL MUSCLE 2 7 0 9 SALIVARY GLAND 6 0 0 6 TETANUS ANTIBODIES 23 0 0 23 TOTAL IGD 11 0 0 11 ANTI-THSD7A 80 0 0 80 TSH RECEPTOR ABS 312 207 73 592 BEEF 5 5 0 10 SAVED SAMPLE - PRE IVIG 29 0 0 29 SECTION 4 – ORGANISATION AND ACCOUNTABILITY The appointee will be contractually accountable to the North Bristol NHS Trust for the provision of services. The appointee will be managerially responsible to the Chief Executive through the Clinical Director. All consultants are required to undergo an annual appraisal carried out in accordance with the Trust policy. Consultants are also required to take an active and co-operative approach to their job planning, which will be reviewed on an annual basis by their Clinical Director. The appointee will be expected to be fully involved in the development of the service, to take account of the Trust policies, including Risk Management Strategy and developments in Clinical Governance. The appointee may be asked to participate in managerial and administrative work and will be expected to be aware of the broader context within the NHS in which Consultants operate. Directorate Management Team: Clinical Director – Dr Kiaran Flanagan General Manager – Ms Valerie Clarke Head of Nursing – Ms Luisa Goddard Clinical Consultants - Immunology & Allergy Dr Mark Gompels – Specialty Lead – Consultant Immunologist, Allergist & HIV Dr Sarah Johnston - Consultant Immunologist, Allergist & HIV Dr Philip Bright – Consultant Immunologist, Allergist & HIV Dr Joe Unsworth (retired, fixed term only) - Consultant Immunologist, Allergist Associate Specialist - Allergy Dr Nikos Tsiougkos Spr Trainee Dr Alexandra Grammatikos, and there is likely to be a second specialty registrar post in the future Nursing staff - Clinical Immunology & Allergy Sister Lisa Smith Sister Jen Whittle Sister Catherine Fox Sister Violetta Alvarez Carbonell Sister Gaynor Rogers SECTION 5 – MAIN DUTIES & RESPONSIBILITES OF THE POST The post holder will be responsible for the diagnosis and clinical management of patients managed by the Clinical Immunology & Allergy Service at North Bristol NHS Trust. The successful applicant will be responsible for; (i) Teaching and Supervision of Junior Medical Staff & Students The post holder will be responsible for the professional supervision and management of junior medical staff. Where appropriate, the post holder will be named in the educational contract of junior staff as the person responsible for overseeing their training and as an initial source of advice to such doctors regarding their careers. In liaison with the Director of Postgraduate Medical Education the post holder may be required to contribute to undergraduate and postgraduate education. Identification of training opportunities and needs across the pathway. Delivery of appropriate ad hoc training as required. Attendance at relevant conferences as required. Be responsible for and maintain own competencies in relation to CPD. Update and extend own clinical and managerial skills appropriate to speciality by attending relevant study sessions and courses. (ii) Study & Research The post holder can request up to a maximum of 30 days study leave within a 3-year period (pro rata for part-time posts) as stated in the Terms and Conditions of Service. The Trust is committed to ensuring that support is given for Continuing Medical Education. The post holder will be required to fulfil the requirements laid down by the relevant Royal College, and to fulfil the requirements for revalidation laid down by the General Medical Council. The post holder will not necessarily be expected to undertake research, however opportunities do exist and encouragement is given to develop collaborative projects with other departments within Trust or with the University of Bristol and the University of the West of England.
Load more

Recommended publications
  • Annual Report and Accounts 2019/20
    University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2019/20 University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2019/20 Presented to Parliament pursuant to Schedule 7, paragraph 25 (4) (a) of the National Health Service Act 2006 © 2020 University Hospitals Bristol NHS Foundation Trust 4 | University Hospitals Bristol NHS Foundation Trust | Annual Report and Accounts 2019/20 Contents 1. Chairman’s Statement ....................................................................................... 7 2. Chief Executive’s Statement ............................................................................. 9 3. Performance Report ......................................................................................... 11 3.1 Overview ........................................................................................................................... 11 3.2 Performance Analysis ....................................................................................................... 21 3.3 Finance Review ................................................................................................................ 25 4. Sustainability Report ....................................................................................... 30 4.1 Overview ........................................................................................................................... 30 4.2 Policies .............................................................................................................................
    [Show full text]
  • University Hospitals Bristol NHS Foundation Trust – 93.0% February 2013; 94.2% Year to Date
    Performance Report For the governing body of South Gloucestershire CCG, to be tabled on 24 April 2013 1 Purpose The purpose of this report is to inform the board current performance of the services commissioned by South Gloucestershire CCG against key access and quality standards. The majority of the standards in this document show performance to February 2013 i.e. month 11 of the 2013/14 financial year, with the exception of urgent care performance standards which are shown to week ending 31 March 2013. The report is intended to provide a variety of level of details. The executive summary below details the current main performance concerns of the South West Commissioning Support Unit Performance Team and is therefore provides a quick overview of current issues. There is also a scorecard attached which shows current progress against all key standards. For a more in depth commentary on performance, the sections of this report will summarise the detail of performance against key standards for: Urgent Care Planned Care Cancer Stroke/TIA Quality indicators e.g. healthcare associated infections The Governing Body is asked to note the contents of the report. Executive Summary The main current areas of concern are shown in the table below: Area Standard Current Commentary Performance Urgent 4hrs: 95% of all As at week The whole health system has been experiencing severe Care patients to be ending 31/03/13: pressure for a number of months and this has been seen, treated, maintained recently, as is demonstrated by performance admitted or 4hrs: against urgent care standards. discharged NBT: 85.76% within 4hrs of UHB: 91.48% Patient flow remains at the core of the problem, although arrival at A&E recently an increase in activity due to issues with the launch of the NHS 111 system has increased pressure Ambulance Handovers: further.
    [Show full text]
  • Mixed Sex Accommodation ‐ Number of Breaches by Month (Provider Basis)
    Mixed Sex Accommodation ‐ Number of Breaches by Month (Provider basis) December January February March April May June July August September October November December Organisation Name Primary Care Trusts Bath And North East Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Bournemouth And Poole PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Cornwall And Isles Of Scilly PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Devon PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Dorset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Gloucestershire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ North Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Plymouth Teaching PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Somerset PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ South Gloucestershire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Torbay Care Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Wiltshire PCT 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Acute Trusts Dorset County Hospital NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Gloucestershire Hospitals NHS Foundation Trust 112 ‐‐‐‐‐‐‐‐‐‐‐‐ Great Western Hospitals NHS Foundation Trust 63 ‐‐‐‐‐‐‐‐‐‐‐‐ North Bristol NHS Trust 538 ‐‐‐‐‐‐‐‐‐‐‐‐ Northern Devon Healthcare NHS Trust 112 ‐‐‐‐‐‐‐‐‐‐‐‐ Plymouth Hospitals NHS Trust 23 ‐‐‐‐‐‐‐‐‐‐‐‐ Poole Hospital NHS Foundation Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Royal Cornwall Hospitals NHS Trust 81 ‐‐‐‐‐‐‐‐‐‐‐‐ Royal Devon And Exeter NHS Foundation Trust 133 ‐‐‐‐‐‐‐‐‐‐‐‐ Royal United Hospital Bath NHS Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ Salisbury NHS Foundation Trust 67 ‐‐‐‐‐‐‐‐‐‐‐‐ South Devon Healthcare NHS Foundation Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ Taunton And Somerset NHS Trust ‐‐‐‐‐‐‐‐‐‐‐‐‐ The Royal Bournemouth And Christchurch Hospitals NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ The Royal National Hospital For Rheumatic Diseases NHS Foundation Trust 0 ‐‐‐‐‐‐‐‐‐‐‐‐ University Hospitals Bristol NHS Foundation Trust 29 ‐‐‐‐‐‐‐‐‐‐‐‐
    [Show full text]
  • For Peer Review Only Journal: BMJ Open
    BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009090 on 11 September 2015. Downloaded from Repeat infusion of autologous bone marrow cells in multiple sclerosis – protocol for a phase I extension study (SIAMMS- II) For peer review only Journal: BMJ Open Manuscript ID: bmjopen-2015-009090 Article Type: Protocol Date Submitted by the Author: 15-Jun-2015 Complete List of Authors: Rice, Claire; University of Bristol, School of Clinical Sciences Marks, David; Bristol Royal Hospital for Children, Adult BMT Unit; University of Bristol, School of Clinical Sciences Walsh, Peter; North Bristol NHS Trust, Neurosciences Kane, Nick; North Bristol NHS Trust, Neurosciences Guttridge, Martin; NHS Blood and Transplant, Redondo, Juliana; University of Bristol, School of Clinical Sciences Sarkar, Pamela; University of Bristol, School of Clinical Sciences; North Bristol NHS Trust, Neurosciences Owen, Denise; North Bristol NHS Trust, Neurosciences Wilkins, Alastair; University of Bristol, School of Clinical Sciences; North Bristol NHS Trust, Neurosciences Scolding, Neil; University of Bristol Institute of Clinical Neurosciences, Neurology http://bmjopen.bmj.com/ <b>Primary Subject Neurology Heading</b>: Secondary Subject Heading: Haematology (incl blood transfusion) Multiple sclerosis < NEUROLOGY, IMMUNOLOGY, Bone marrow Keywords: transplantation < HAEMATOLOGY on September 30, 2021 by guest. Protected copyright. For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 1 of 11 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009090 on 11 September 2015. Downloaded from 1 2 3 Repeat infusion of autologous bone marrow cells in multiple sclerosis – a 4 phase I extension study (SIAMMS-II) 5 6 7 8 Claire M. Rice1,2*, David I.
    [Show full text]
  • North Bristol NHS Trust Quality Account 2020/21
    North Bristol NHS Trust Quality Account 2020/21 Exceptional healthcare, personally delivered Contents 04 Part 1: A statement on quality from the chief executive 08 Part 2: Priorities for improvement and statements of assurance from the board 2.1 Priorities for improvement: 09 Priority one: Ensure quality and safety of services is sustained whilst recovering from the impact of the COVID-19 pandemic; including: • Maintaining excellence in infection prevention and control • Ensuring the appropriate clinical priorities for recovery work • Keeping people waiting for planned care safe • Maintaining safety and excellent outcomes from emergency care 11 Priority two: Being outstanding for Safety—a national leader in implementing the NHS Patient Safety Strategy 13 Priority three: Ensuring excellence in our maternity services, delivering safe and effective maternity care 15 Priority four: Meeting the identified needs of patients with learning difficulties, autism, or both 2.2 Statements from the board 17 Review of services 19 Care Quality Commission 21 Research and Innovation 22 Operational Performance 27 Hospital Episode Statistics and DQIPs 28 Clinical Coding Performance 29 Clinical Coding Improvement Strategy 30 Data Security & Protection Toolkit 32 Part 3: Our quality indicators 3.1 Patient Safety 32 Patient Safety Indicators 33 Freedom to Speak Up 34 Guardian for safe working hours 35 Quality Indicators 37 Safeguarding Adults 38 Safeguarding Children 3.2 Clinical Effectiveness 39 Getting It Right First Time (GIRFT) - specialty outcomes 40 Mortality
    [Show full text]
  • University Hospitals Bristol NHS Foundation Trust Annual Report
    University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2010 – 2011 University Hospitals Bristol NHS Foundation Trust Annual Report and Accounts 2010 – 2011 Presented to Parliament pursuant to Schedule 7, paragraph 25(4) of the National Health Service Act 2006 Table of Contents 1. Chairman’s Statement ................................................................................................... 1 2. Chief Executive’s Foreword ........................................................................................... 3 Introduction........................................................................................................................ 3 Histopathology Inquiry ....................................................................................................... 3 Clinical services ................................................................................................................. 3 Research and innovation ................................................................................................... 4 Teaching and learning ....................................................................................................... 5 Board of Directors.............................................................................................................. 5 Looking forward ................................................................................................................. 6 3. Directors’ Report ...........................................................................................................
    [Show full text]
  • Bristol Mayor, Marvin Rees, Opens BASF Wellbeing Day 2016
    Winter 2016-17 INSIDE: BASF NEWSLETTER Page 2 - Occupational Bristol Mayor, Therapy students experience life with BASF Marvin Rees, opens BASF Wellbeing Day 2016 BASF was hugely grateful to Mayor of Bristol, Marvin Rees, for opening our Wellbeing Day on 30th September 2016. He introduced the day with a brilliant personal account of the impact of stroke. As a young community worker, he supported an Page 10 - Fundraisers of individual on his journey to life after stroke. He supported him the Year raise awareness about stroke through supporting his personal challenge of climbing up PenYFan, attracting much media attention. Marvin Rees noted that it was not just the physical impact of stroke that people needed support with but also the emotional impact, and that families and carers also need support and the voluntary sector plays a key role in this. Page 12 - Service user to volunteer – Len Osgood’s stroke story BRISTOL AREA STROKE FOUNDATION The Gatehouse Centre, Hareclive Road, Hartcliffe, Bristol, BS13 9JN T: 0117 964 7657 Left to right: BASF Operations Manager, Rebecca Sheehy; [email protected] Bristol Mayor, Marvin Rees; Dr. Philip Clatworthy Consultant www.basf.uk.com Stroke neurologist at North Bristol NHS Trust; Dr Praveen Kumar, Charity number 287554 Senior Lecturer in Physiotherapy, University of West of England. continued on page 6 ➤ SUPPORTING PEOPLE AFFECTED BY STROKE continued on page 2 ➤ Dates for your diary 2017 ACTion After Stroke (4/5 weeks) Bristol Stroke Café Date: Tuesday 21st February – Tuesday 21st March Monthly, every
    [Show full text]
  • CQC Evidence Appendix
    North Bristol NHS Trust Evidence appendix North Bristol NHS Trust Date of inspection visit: Southmead Hospital 8 Nov to 29 Nov 2017 Southmead Road Bristol BS10 5NB Date of publication: 6 March 2018 Tel: 0117 950 5050 www.nbt.nhs.uk This evidence appendix provides the supporting evidence that enabled us to come to our judgements of the quality of service provided by this trust. It is based on a combination of information provided to us by the trust, nationally available data, what we found when we inspected, and information given to us from patients, the public and other organisations. For a summary of our inspection findings, see the inspection report for this trust. Facts and data about this trust Details of sites and locations registered with CQC Three locations are registered with the Care Quality Commission. Southmead Hospital Cossham Hospital Frenchay Hospital We only inspected Southmead Hospital as part of this inspection. Background to the trust North Bristol NHS Trust is an acute trust located in Bristol that provides acute hospital and some community services to a population of about 900,000 people in Bristol, South Gloucestershire and North Somerset. The trust is not a foundation trust. It also provides specialist services such as neurosciences, renal, trauma and plastics/burns to people from across the South West and in some instances nationally or internationally. The new hospital at Southmead opened in May 2014 when the main hospital at Frenchay closed. Southmead Hospital provides a full range of acute clinical services. The trust also provides community healthcare for children and young people.
    [Show full text]
  • North Bristol NHS Trust Strategy 2016-2021
    North Bristol NHS Trust Strategy 2016-2021 Contents 1 Executive summary 04 2 Introduction 06 3 Our values and vision 08 4 Strategic themes 10 5 Next steps and delivery plan 20 6 Conclusion 22 7 Appendix A: North Bristol NHS Trust today 24 8 Appendix B: The challenges we face 30 1 | Executive summary North Bristol NHS Trust Achieving our vision to provide This strategy has been the high quality care that we developed for the period 2016 - is a provider of local aspire to within the resources 2021 to provide focus and clarity hospital services and available is an increasing of direction for our organisation complex specialist care challenge. By improving patient and its stakeholders. It takes flow, maximising productivity, into account detailed analysis for a large population using resources including our of the Trust, activity, quality, in the South West of workforce wisely, and sharing performance, outcomes, England. Employing over best practice across the Trust, opportunities and challenges, our finances will be sustainable and is informed by clinician, 8,000 highly skilled and and we will meet the national staff and patient views. caring staff, we aim to standards for operational The detail of this analysis is performance in the coming described in appendices A & B: deliver excellent clinical years. The aims described in The eight strategic themes that outcomes and a great this strategy are designed to will form the basis of our plans create an organisation in which experience for all service over the next five years are: the necessary savings and users: exceptional efficiencies are delivered to 1) Change how we deliver healthcare, personally enable us to do more with the services to generate delivered.
    [Show full text]
  • 1 Reference: FOI 27719 BNSSG 15C Subject: Facial Nerve Palsy I Can
    Reference: FOI 27719 BNSSG 15C Subject: Facial Nerve Palsy I can confirm that the CCG does hold some of the information requested; please see responses below: QUESTION RESPONSE Bristol, North Somerset and South Gloucestershire CCG does not hold this 1. Of those with facial nerve palsy who have information. The provider trusts may be able to not made a full or nearly full recovery at provide this information. If you would like to 12 weeks following onset, can you redirect your Freedom of information request provide an estimate of the percentage of please follow the links. such patients who are referred for rehabilitation of persistent facial University Hospitals Bristol NHS Foundation pain/discomfort and dysfunction? Trust North Bristol NHS Trust Persistent facial nerve palsy – most common presentation (outside of surgical complication, in which case referral would come from the surgical team, not primary care) – the CCG would follow the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries (CKS) as below: Refer urgently to neurology or to ear, nose, and throat (ENT) if there is: o Any doubt regarding the diagnosis. o Recurrent Bell's palsy. 2. If a patient with facial nerve palsy is o Bilateral Bell's palsy. routinely referred to secondary care for If the cornea remains exposed after rehabilitation therapy, which hospital(s) attempting to close the eyelid, refer urgently and department(s) do you refer to? to ophthalmology. If the paralysis shows no sign of improvement after 1 month, or there is suspicion of a serious underlying diagnosis (for example, cholesteatoma, parotid tumour, malignant otitis externa), refer urgently to ENT.
    [Show full text]
  • Choosing Your Hospital, Contact: Choosing Your Hospital
    hospital North Somerset Primary Care Trust your Choosing PHOTOGRAPHY COPYRIGHT: ALAMY, GETTY, JOHN BIRDSALL, NHS LIBRARY, REX, SPL, ZEFA/CORBIS copy of this booklet is also Crown copyright 2005. available on: www.nhs.uk A Tel: 01454 883655 BS37 4AF Bristol Yate 248 Station Road Chipping Sodbury Memorial Day Centre Referral Management Centre Patient Choice Coordinator For more help with choosing your hospital, contact: © 270744/151 What is patient choice? Things to think about If you and your GP decide that you need to see a specialist Where can I go for treatment? for further treatment, you can now choose where to have You might already have experience of a particular hospital or know someone who has. Now you can choose – where would you like to go? Or, if you like, your treatment from a list of hospitals or clinics. From April, your GP can recommend a hospital where you can be treated. you may have an even bigger choice – full details will be How do I find out more information on the NHS website (www.nhs.uk). about my condition? Your GP should be able to give you the answers to some of the questions This guide explains more about how the process works. you have. Or contact NHS Direct: visit www.nhsdirect.nhs.uk or call It also gives you answers to some questions you may have. 0845 4647 and ask to speak to a health information advisor. Plus, there are details of the hospitals you can choose and How long will it take? some information to help you choose the one that will be How quickly do you want to be treated? Would you be willing to travel best for you.
    [Show full text]
  • North Bristol NHS Trust Job Description
    North Bristol NHS Trust Exceptional healthcare, personally delivered Job Description SECTION 1 – JOB DETAILS Job Title: Consultant Histopathologist Division: Core Clinical Services Location/Base: Southmead Hospital, Bristol SECTION 2 – THE WORK OF THE DEPARTMENT North Bristol NHS Trust is seeking a full-time (10 PAs) substantive Consultant Histopathologist within the Department of Cellular Pathology. This is a replacement post. It is expected that the appointee will have an established or developing interest in Gastrointestinal (GI) Pathology and will join a team of 3 specialists and 4 non-care GI Pathologists. As we are growing our service across all sub-specialisms, additional interest in Head and Neck Pathology and Endocrine Pathology is highly desirable. Severn Pathology Severn Pathology lies at the heart of patient care. Severn Pathology’s mission is to provide a best in class, high quality, innovative, value for money Pathology service that serves the needs of the healthcare market in the South West region and beyond. In doing so, we will strive to put Pathology at the heart of a modern patient pathway, serving an increasingly diverse market. The combination of general pathology services with a thriving and growing genetics laboratory service will ensure continued development of state of the art pathology services in to the future. On 1 May 2016, North Bristol NHS Trust’s (NBT) Department of Cellular Pathology and the Department of Histopathology at the University Hospitals Bristol NHS Foundation Trust (UHB) merged and co-located the bulk on their services to a new, purpose-built facility on the Southmead Hospital site. The service is managed by NBT which also manages the Essential Services Laboratory and Paediatric / Perinatal mortuary located on UHB premises.
    [Show full text]